Literature DB >> 2424173

Characterization of epitopes on the measles virus hemagglutinin.

H Sheshberadaran, E Norrby.   

Abstract

Measles virus hemagglutinin epitopes were analyzed using nine monoclonal antibodies (MAbs) in competitive binding assays (CBA) and by in vitro selection of antigenic variants. In CBA the nine MAbs formed four different but partially overlapping binding groups. In vitro selected variants were analyzed by radioimmune precipitation assay, hemagglutination inhibition (HI), and neutralization assays. Seven operationally distinct MAb antigenic sites could be delineated: two sites were defined by two MAbs to each and five sites by single MAbs. Variants which had lost reactivity to different combinations of MAbs were generated by a branched sequential selection procedure. The most epitopically modified variants had lost reactivity in all assays to eight MAbs. None of these variants showed any major changes in hemagglutination nor neurotropism per se. Only minor changes were detected by HI in reactivity of these variants with human measles antiserum indicating that the epitopic changes were not of major epidemiological significance at least in terms of HI.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424173     DOI: 10.1016/0042-6822(86)90371-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.

Authors:  J P Langedijk; F J Daus; J T van Oirschot
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Exposure to acidic pH causes irreversible conformational changes in the measles virus hemagglutinin.

Authors:  H Sheshberadaran
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance.

Authors:  S J Schrag; P A Rota; W J Bellini
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Mice immunized with measles virus develop antibodies to a cell surface receptor for binding virus.

Authors:  D L Krah; P W Choppin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.

Authors:  C Prehaud; P Coulon; F LaFay; C Thiers; A Flamand
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Protein antigen-monoclonal antibody contact sites investigated by limited proteolysis of monoclonal antibody-bound antigen: protein "footprinting".

Authors:  H Sheshberadaran; L G Payne
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

9.  Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed.

Authors:  Vincent H J Leonard; Patrick L Sinn; Gregory Hodge; Tanner Miest; Patricia Devaux; Numan Oezguen; Werner Braun; Paul B McCray; Michael B McChesney; Roberto Cattaneo
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.